Synergy Pharmaceuticals (FRA:S90) Days Sales Outstanding : 72.81 (As of Sep. 2018)

View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Days Sales Outstanding?

Synergy Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2018 was €7.59 Mil. Synergy Pharmaceuticals's Revenue for the three months ended in Sep. 2018 was €9.52 Mil. Hence, Synergy Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2018 was 72.81.

The historical rank and industry rank for Synergy Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

FRA:S90' s Days Sales Outstanding Range Over the Past 10 Years
Min: 81.41 Med: 140.86 Max: 140.86
Current: 81.41

During the past 12 years, Synergy Pharmaceuticals's highest Days Sales Outstanding was 140.86. The lowest was 81.41. And the median was 140.86.

FRA:S90's Days Sales Outstanding is not ranked
in the Drug Manufacturers industry.
Industry Median: 71.845 vs FRA:S90: 81.41

Synergy Pharmaceuticals's Days Sales Outstanding increased from Sep. 2017 (63.10) to Sep. 2018 (72.81).

Synergy Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Synergy Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Days Sales Outstanding Chart

Synergy Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Days Sales Outstanding

Get a 7-Day Free Trial

140.86

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Days Sales Outstanding	Get a 7-Day Free Trial															63.10	55.77	75.34	57.84	72.81

Competitive Comparison of Synergy Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synergy Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's Days Sales Outstanding falls into.

Synergy Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Synergy Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2017 is calculated as

	Days Sales Outstanding (A: Dec. 2017 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2016 )	+	Accounts Receivable (A: Dec. 2017 ))	/	count )	/	Revenue (A: Dec. 2017 )	*	Days in Period
=	( (0	+	5.485)	/	1 )	/	14.213	*	365
=	5.485					/	14.213	*	365
=	140.86

Synergy Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2018 is calculated as:

	Days Sales Outstanding (Q: Sep. 2018 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2018 )	+	Accounts Receivable (A: Sep. 2018 ))	/	count )	/	Revenue (A: Sep. 2018 )	*	Days in Period
=	( (7.285	+	7.903)	/	2 )	/	9.517	*	365 / 4
=	7.594					/	9.517	*	365 / 4
=	72.81

Synergy Pharmaceuticals (FRA:S90) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Synergy Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170

Website

http://www.synergypharma.com

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines